Nanotechnology-based chemotherapeutics and imaging agents represent a new era of
“cancer nanomedicine” working to deliver versatile payloads with favorable …

Nanomedicine is a development of nanotechnology in medical research that can be used to
discover an advanced treatment for all types of cancer. Conventional drug delivery systems …

Cancer is one of the most prevalent causes of mortality worldwide. The arena of cancer
diagnosis and therapy has undergone a tremendous revolution since the development of …

Glioma stem cells (GSCs) and their complex microenvironment play a crucial role in the high
invasion of cancer and therapeutic resistance and are considered to be the most likely …

Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis and high
mortality, with no curative treatment to date as limited trafficking across the blood–brain …

The recent advent of nanomedicine holds potential to revolutionize cancer therapy. This
innovative discipline has paved the way for the emergence of a new class of drugs based on …

Diagnosing and treating glioblastoma patients is currently hindered by several obstacles,
such as tumor heterogeneity, the blood-brain barrier, tumor complexity, drug efflux pumps …

Glioblastoma (GBM) is one of the most aggressive and deadliest central nervous system
tumors, and the current standard treatment is surgery followed by radiotherapy with …

Anticancer nanomedicines have been studied over 30 years, but fewer than 10 formulations
have been approved for clinical therapy today. Despite abundant options of anticancer …

With the integration of nanotechnology into the medical field at large, great strides have
been made in the development of nanomedicines for tackling different diseases, including …